NCT01104584View on ClinicalTrials.gov

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

January 31, 2012

Conditions
Breast Cancer
Interventions
DRUG

Gadobutrol (Gadavist, Gadovist, BAY86-4875)

A single bolus injection of gadobutrol 1.0 M; 0.1 mmol/kg body weight

Trial Locations (48)

100

Taipei

110

Taipei

114

Taipei

402

Taizung

5623

Eindhoven

10065

New York

10115

Berlin

14004

Córdoba

17002

Girona

17489

Greifswald

37081

Göttingen

37099

Göttingen

43212

Columbus

44892

Bochum

48145

Münster

48149

Münster

60596

Frankfurt am Main

60637

Chicago

78229

San Antonio

80112

Englewood

81377

München

85724

Tucson

91054

Erlangen

94609

Oakland

98321

Tacoma

110085

Delhi

400012

Mumbai

02903

Providence

C1082A

Buenos Aires

C1181ACH

Buenos Aires

C1425BEE

Buenos Aires

L8N 4A6

Hamilton

M5G 2M9

Toronto

M5S 1B2

Toronto

H4J 1C5

Montreal

07548

Gera

400 004

Mumbai

6229 HX

Maastricht

6525 GA

Nijmegen

85-796

Bydgoszcz

44-100

Gliwice

30-501

Krakow

70-111

Szczecin

02-781

Warsaw

08036

Barcelona

08208

Sabadell

Unknown

Alzira

Taichung

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY